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Summary
Babesiosis due to Babesia bigemina is a relevant tick-borne disease, affecting cattle worldwide. 
Many surface proteins of the pathogen including the Apical Membrane Antigen 1 (AMA-1) - 
have been analysed for vaccine and diagnostic purposes. This study focused on B. bigemina 
AMA-1 and on its use for the assessment of diagnostic tests. After bioinformatic analyses, 
AMA-1 codifying region was amplified and cloned into an expression vector used to induce 
protein synthesis in Escherichia coli cells. AMA-1 was purified by affinity chromatography 
and used to set up the best condition for an ELISA protocol. Bovine field sera positive to B. 
bigemina were used to evaluate the presence of anti-AMA-1 antibodies. In order to verify 
the assay specificity, sera positive to Babesia bovis or to the piroplasm Theileria annulata 
were also included. Significant differences were obtained between sera negative to both B. 
bigemina and B. bovis and samples positive to B. bigemina, to B. bovis or to both pathogens. 
No significant reaction was observed with T. annulata positive sera. The results showed that 
AMA-1 protein is suitable to be used as antigen in diagnostic assays for babesiosis diagnosis 
in cattle, as it does not show any cross reaction with anti-T. annulata antibodies.
Riassunto
La Babesiosi causata da Babesia bigemina è una malattia trasmessa da zecche che colpisce gli 
allevamenti bovini in diverse aree del mondo. Molte proteine di superficie del patogeno - tra 
cui anche l’Apical Membrane Antigen 1 (AMA-1) - sono state studiate al fine di realizzare nuovi 
vaccini e ottenere nuovi metodi diagnostici. Questo studio è stato condotto sulla proteina 
AMA-1 di B. bigemina e sul suo possibile utilizzo nella messa a punto di nuovi test diagnostici. 
In seguito a studi bioinformatici, la regione codificante la proteina AMA-1 è stata amplificata 
e clonata all’interno di un vettore di espressione. Il vettore ricombinante è stato utilizzato per 
indurre la sintesi proteica in cellule di Escherichia coli. La proteina AMA-1 è stata purificata 
mediante cromatografia d’affinità e utilizzata per ottimizzare le condizioni per il protocollo 
ELISA. Sieri di bovini di campo, risultati positivi a B. bigemina, sono stati utilizzati per rilevare 
la presenza di anticorpi anti-AMA-1. Al fine di verificare la specificità del saggio, sono stati 
inclusi nell’analisi sieri positivi a Babesia bovis o al piroplasma Theileria annulata. I sieri positivi 
a B. bigemina, B. bovis o ad entrambi i patogeni hanno mostrato risposte significativamente 
differenti rispetto ai sieri negativi sia a B. bigemina che a B. bovis. Non è stata osservata alcuna 
reazione significativa in presenza di sieri positivi a T. annulata. Lo studio ha mostrato che la 
proteina AMA-1 di B. bigemina può essere impiegata come antigene nei test per la diagnosi 
della babesiosi nei bovini, in quanto non mostra alcuna cross-reattività nei confronti degli 
anticorpi anti-T. annulata.
Un nuovo test ELISA per la diagnosi della babesiosi bovina basato 
sull’Apical Membrane Antigen‑1 di Babesia bigemina
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a B.  bigemina surface antigen conserved enough 
among different strains of the pathogen. DAMBE (Xia 
and Xie 2001) and MEGA (Kumar et al. 2008, Tamura 
et al. 2007) software were used to obtain similarity 
percentage among the analysed sequences. 
Apical Membrane Antigen-1 codifying region 
was amplified from DNA extracted from blood 
of a bovine naturally infected by B.  bigemina 
and the amplification product was cloned into 
the expression vector pET160/GW/D-TOPO (Life 
Technologies Corporation™, Carlsbad, CA, United 
States), following the manufacturer’s instruction. 
The construct was initially used to transform One 
Shot® TOP10 Chemically Competent Escherichia 
coli cells (Life Technologies Corporation™, Carlsbad, 
CA, United States). The plasmid was thus extracted, 
purified, and sent to Macrogen Europe (Amsterdam, 
The Netherlands) for sequencing using T7F and T7R 
universal primers in order to test if the PCR product 
was cloned in the correct direction. The recombinant 
plasmid was then used to transform E.  coli BL21 
Star™ (DE3) cells (Life Technologies Corporation™, 
Carlsbad, CA, United States). Bacterial cells were 
cultured in LB-Broth at 37°C. Bacterial cell growth 
was monitored by reading the Optical Density 
(O.D.) at 600 nm up to the value of approximately 
0.6  and then the protein production was induced 
by 0.75  mM  IPTG (isopropil-tio-β-Dgalattoside). 
After 3 hours of induction, bacteria were collected 
and treated as previously described (Gallo et  al. 
2012). Briefly, pellets were cleaned 3 times with 
a washing solution (10 mM Tris-HCl pH 7.5, 
5 mM EDTA, 1  mM  DTT, 0.5 mM PMSF, 4 mg/
ml leucopeptin, 0.7  mg/ml pepstatin, 5 mg/ml 
benzamidin). Following re-suspension in washing 
solution containing 0.3% SDS, bacterial cells were 
disrupted by sonication on ice (output control 4, 
4 x 15 s, Vibra Cell, Sonics & Materials, Inc., Newtown, 
CT, USA). Samples were then boiled (5 minutes) and 
rapidly cooled down on ice (15 minutes). DNase 
(100 μg/ml) and RNase (50 μg/ml) were added 
in ice for 20  minutes. Cell debris and non-broken 
cells were separated by centrifugation at 15,000 
x g, for 15  minutes, at 4°C. Protein solutions were 
precipitated by using 3 volumes of acetone, at -20°C, 
overnight, and re-suspended in mQ H2O.
Recombinant AMA-1 protein was thus purified 
using HisGraviTrapTM kit (GE HealthCare, 
Little Chalfont, niUted Kingdom) following 
manufacturer’s instruction, and then digested with 
AcTEV Protease (Life Technologies Corporation™, 
Carlsbad, CA, United States) for 3 hours at 30°C to 
remove the His Tag from the fusion protein. After 
the digestion, proteins were newly purified with 
HisGraviTrapTM kit (GE HealthCare, Little Chalfont, 
Buckinghamshire, United Kingdom) to eliminate 
the protease, the undigested recombinant proteins 
and the cleaved tags. Protein extracts were analysed 
Introduction
Cattle babesiosis is a tick-borne disease caused by 
apicomplexan protozoan such as Babesia bovis and 
Babesia bigemina. The pathology affects cattle in 
many areas of the world, strongly reducing meat 
and milk production (Bock et  al. 2004, Torina and 
Caracappa 2007). Understanding the basic molecular 
mechanism of merozoite invasion of erythrocytes 
may improve the development of an effective 
control strategy. Host-cell invasion by apicomplexan 
parasites is a complex, multistep process (Black 
and Boothroyd 2000), as a number of proteins are 
implicated in it, although in most cases their precise 
functions remain unknown (Zhou et al. 2006).
One of the molecules potentially involved in the 
erythrocyte invasion by B.  bigemina is the Apical 
Membrane Antigen-1 (AMA-1), an apically located 
protein that is shared by many Apicomplexa and has 
a role in the host red blood cells invasion process. 
While the biological function of AMA-1 is not 
completely understood, its cellular localization, a 
phase-specific expression, and the secretion during 
the host cell invasion suggest that this protein could 
have a key role in the red blood cell penetration by 
the parasite.
The most characterized AMA-1 protein is the 
one codified by Plasmodium falciparum (PfAMA) 
(Peterson et  al. 1989). This protein has been 
extensively studied as it is one of the most promising 
erythrocyte stage candidates among the few 
anti-malarial vaccine candidates under development 
(Latitha et  al. 2008). Babesia bovis AMA-1 protein 
(BbAMA-1) was identified and characterized in 2004 
(Gaffar et al. 2004) and it showed structural features 
similar to those of other AMA-1 proteins (Yokoyama 
et al. 2006). It is supposed that also Babesia bigemina 
invades erythrocytes using an Apical Membrane 
Antigen-1. Babesia bigemina AMA-1 is a 65.9KDa 
protein showing several common features with 
other AMA-1 family members. It also exhibits a high 
degree of similarity with the orthologue gene of 
B.  bovis. Structural features of B.  bigemina AMA-1 
protein were recently described (Torina et al. 2010).
This study was devoted to the synthesis of B. bigemina 
AMA-1 recombinant protein into a prokaryotic 
expression system and its use to asses a new ELISA 
test useful for diagnosis of cattle babesiosis.
Material and methods 
B. bigemina AMA‑1 production in E. coli 
Bioinformatic analyses were performed using 
ClustalW2.0.10 (Larkin et  al. 2007) software for 
sequence alignment with the purpose to select 
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Field samples tested in the study
In order to investigate the specificity of the new 
B.  bigemina AMA-1 based ELISA, the assay was 
used to analyse field serum samples that had been 
previously tested by serological and molecular 
techniques and to verify their positivity/negativity to 
B. bigemina and its closely related organisms B. bovis 
and T. annulata. In particular, bovine serum samples 
were analysed using a commercial ELISA kit for the 
presence of antibodies against B. bigemina (Svanova 
Biotech AB, Uppsala, Sweden) and an IFA kit for 
the detection of antibodies against B.  bovis (Fuller 
Laboratories, Fullerton, CA, United States) following 
the manufacturer’s instructions. The presence of 
antibodies against T.  annulata was assessed by 
immunofluorescence using a protocol modified 
from Burridge and Kimber (Burridge and Kimber 
1972) so to find out the serum antibody titres to 
Theileria infection. For molecular analysis, DNA was 
extracted from EDTA-treated blood samples using 
the PureLink Genomic Mini kit (Life Technologies 
Corporation™, Carlsbad, CA, United States) following 
the manufacturer’s instructions. DNA samples were 
analysed by polymerase chain reaction (PCR) to 
detect the presence of DNA from Babesia bovis 
(Figueroa et  al. 1993), B.  bigemina (Figueroa et  al. 
1993), and T.  annulata (D’Oliveira et  al. 1995). PCRs 
were performed in a reaction buffer containing 
1.5 mM MgCl2, 0.2 mM dNTPs, forward and reverse 
primers at a concentration of 0.4 mM, and 0.025 U/μl 
of Taq DNA polymerase (5 U/μl) (Promega, Madison, 
WI, United States). For each reaction, a positive 
control consisting of pathogen DNA and a negative 
control in which DNA was replaced by water 
were used. Polymerase chain reaction products 
were visualized after agarose gel electrophoresis 
containing 10 μg/ml ethidium bromide. 
Following serological and molecular analyses, 
136  sera were divided into 6 groups according to 
their positivity/negativity for B.  bigemina, B.  bovis, 
and T.  annulata pathogens. In detail, Group 1 
included samples positive for B. bigemina, B. bovis 
and T. annulata (26 samples). Group 3 comprised 
16 samples positive for B. bovis and B. bigemina but 
negative for T. annulata. Group 2 comprehended 
samples that were positive only for B.  bovis 
(26  samples), Group 4 comprehended samples 
positive only for B. bigemina (28 samples). Samples 
that were positive (22 samples) only for T. annulata 
were enclosed in Group 5 while Group 6 included 
18 samples negative to all three pathogens. 
Statistical analysis of the results was performed by 
ANOVA test. Threshold O.D. values were determined 
to discriminate B.  bigemina/B.  bovis positive from 
negative sera. The threshold O.D. values were 
obtained by analysing the distribution frequencies of 
the O.D. values normalized according to Gauss’ curves.
by SDS-gel electrophoresis after staining with 
Lumio™ Green Detection Kit (Life Technologies 
Corporation™, Carlsbad, CA, United States). The 
Lumio™ Green Detection Reagent is non-fluorescent 
and becomes fluorescent upon binding to the 
tetracysteine Lumio™ tag codified by the expression 
vector, allowing the specific visualization of the 
recombinant protein at UV light. As an alternative 
to the Lumio™ Green Detection, the protein was 
stained with 0.005% Blue Coomassie (Coomassie 
Brillant Blue R-250) (w/v). The protein was quantified 
by Bradford protein assay.
B. bigemina AMA‑1 based ELISA 
optimization
The obtained protein was used to set up an ELISA 
protocol. ELISA tests were performed in 96 well 
plates (MaxiSorp, NUNC, Roskilde, Denmark). 
Apical Membrane Antigen-1 protein in carbonate/
bicarbonate buffer (0.1 M NaHCO3 in distilled 
water pH 8.2 Sigma-Aldreich, St. Louis, Missouri, 
United States) was used to coat plate wells at 4°C 
over nigth. Then, 5% BSA solution to saturate free 
sites of the wells, serum samples, and Anti-bovine 
IgG secondary antibody conjugated with 
Peroxidase (Sigma- Aldreich, St. Louis, Missouri, 
United States) were added in this order. After the 
addition of the specific substrate (SigmaFastTM 
OPD, Sigma-Aldreich, St.  Louis, Missouri, United 
States), O.D. values were determined at 405 nm 
at spectrophotometer (Mod 680, Biorad, Hercules, 
CA, United States) or, if the plate could not be 
read immediately, 3M H2SO4 were added and the 
stopped reactions were read at 490 nm. 
Different concentrations and incubation times for 
all of these reagents were tested to find the optimal 
conditions for the assay. To validate our results, serum 
samples were tested in duplicate and in all plates, 
foetal bovine serum (FBS) was used as negative 
control, while blank samples were included replacing 
sera with the same volume of Phosphate-buffered 
saline (PBS). Field serum samples were previously 
selected and tested by serological and molecular 
techniques, as described in the section ‘Field samples 
tested in the study’, in order to verify their positivity/
negativity to B.  bigemina and their closely related 
organisms B. bovis and Theileria annulata.
One sample, which resulted positive at both 
serological and molecular tests, was then used as 
positive control. Another sample, which was negative 
at serological and molecular tests, was subsequently 
used as negative control. These 2  samples were 
included in all the plates to verify result reproducibility. 
Antibody titers were considered positive when they 
yielded an O.D. 405 nm value at least twice as high as 
the negative field sera.
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coating buffer (bicarbonate/carbonate at pH  8.2, 
Sigma-Aldreich, St. Louis, Missouri, United States). 
After 5 washes with PBS Tween, plated were 
saturated with 5% BSA in PBS (100  μl/well) for 
2 hours and 30 minutes at 37°C. Plates were washed 
5 times with PBS Tween, sera diluted (1:100) in PBS 
Tween were added and incubated for 1 hour at 
37°C (100 μl/well). After 5 washes with PBS Tween, 
secondary antibody (Anti-bovine IgG-Peroxidase 
antibody, Sigma-Aldreich, St. Louis, Missouri, United 
States) diluted 1:10,000 in PBS-Tween was added 
and incubated for 1 hour at 37°C (100 μl/well). 
Plates were washed with PBS Tween 5 times and, 
then, fast OPD substrate (100 μl/well) was added 
(Sigma-Aldreich, St. Louis, Missouri, United States) 
and plates were read at a spectrophotometer at 
405 nm after 20  minutes of incubation at room 
temperature. All the plates showed O.D. values 
of 0.1  for FBS and between 0.2  and 0.1 for blank 
samples. 
The average values of each individual group are 
shown in Table I. 
The statistical analysis performed by ANOVA test 
among the different groups confirmed a significant 
difference between samples that were positive for 
B.  bigemina and/or B.  bovis and samples that were 
negative for these 2 pathogens. No significant 
reaction was observed in presence of T.  annulata 
positive sera. 
Moreover, we did not find significant differences 
between the samples of Groups 1 and 3 positive 
for both B. bovis and B. bigemina, which were then 
grouped in Group A, so it was the case for Group 2 
and Group 4 (B.  bovis or B.  bigemina positive, 
respectively), grouped in Group B, and samples 
of Group 5 and Group 6 (negative for both B. bovis 
and B. bigemina, positive or negative for T. annulata) 
unified in group C. It was not possible to unify the 
samples of Groups A and B into a single group 
because the values of the samples of Group A 
showed O.D. values significantly higher (1.15 ± 0.12) 
than those of Group B (0.94 ± 0.15).
Values obtained by the ELISA test for groups A, B, 
and C with their means, standard deviations, and 
number of samples are summarized in Table II.
Cut-off value to discriminate B.  bigemina/B.  bovis 
positive sera from the negative ones was recognised 
at 0.55 O.D., in such a way as to favour the sensitivity 
with respect to the specificity of the assay. In 
particular, it can be established that, following the 
specific optimised protocol, samples with O.D. lower 
than 0.55 can be considered reasonably negative. 
In contrast, values of O.D. greater than 0.69 indicate 
positivity to at least 1 of the 2 considered Babesia. 
The intermediate value of O.D. (between 0.55 and 
0.69) could be considered doubtful, so for these 
Results 
Recombinant B. bigemina AMA‑1 in 
E. coli production
The region codifying AMA-1 protein was amplified 
by PCR and the amplification product was inserted 
into the expression vector. The correct orientation 
of the cloned fragment was confirmed by sequence 
analysis. Obtained recombinant plasmid was used 
to transform BL21 Star™ (DE3) E.  coli cells (Life 
Technologies Corporation™, Carlsbad, CA, United 
States). Protein expression was induced by IPTG 
and, after 3 hours, pellets were collected. Obtained 
cell suspensions were lysed and treated to extract 
the total protein pattern that was separated by 
SDS-PAGE and visualized by staining with Lumio 
Green™ (Life Technologies Corporation™, Carlsbad, 
CA, United States) as shown in Figure 1A. Protein 
purification by affinity chromatography was verified 
by SDS-PAGE (Figure 1B).
B. bigemina AMA‑1 ELISA results
Recombinant protein was used for the assessment 
of an ELISA test. The optimum conditions of the 
test included the coating of individual wells 
of a microtiter plate (Nunc) with 0.1 μg/well of 
AMA-1 antigen overnight at 4°C in an antigen 
Figure 1. A. SDS-PAGE of total protein extracts from E.coli cells allowed to 
grow for 3 hours in absence (lane 1) or in presence (lane 2 and 3) of IPTG, 
stained with Lumio™ Green Detection Kit (Life Technologies Corporation™, 
Carlsbad, CA, United States) and observed at UV light. B. SDS-PAGE of 
the recombinant protein after purification by affinity chromatography, 
stained with Lumio™ Green Detection Kit (Life Technologies Corporation™, 
Carlsbad, CA, United States) and observed at UV light.
A B
1 2 3 1
76 kDa
52 kDa
38 kDa
76 kDa
52 kDa
38 kDa
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among the different examined organisms (Torina 
et al. 2010), so the choice to include samples positive 
for B. bovis and T. annulata in the analysis is justified.
Obtained results suggest the use of this assay 
for screening purposes in order to enable a rapid 
diagnosis and lower costs of the reaction. In case 
of a negative reaction, in fact, it should not be 
necessary to carry out species-specific serological 
tests that would be performed only on those serum 
samples positive at the first screening. 
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samples it may be appropriate to repeat the test on 
a withdrawal made after 2 weeks. 
Discussion and conclusions
This work describes the optimisation of a 
prokaryotic system for AMA-1 recombinant protein 
production and the use of the produced antigen 
for a new diagnostic ELISA test. Obtained results 
showed a significant signal difference among the 
analysed serum samples, confirming the presence 
of B.  bigemina antibodies directed against AMA-1 
protein in infected bovine sera and suggesting 
that B.  bigemina AMA-1 protein is sufficiently 
immunogenic and conserved to be recognised by 
antibodies against B. bovis, as it can be observed also 
in the amino acidic alignment showed in Figure 2. 
The higher O.D. values of the samples of Group A are 
probably due to presence in these sera of antibodies 
to both B. bigemina and B. bovis able to determine a 
stronger response to the antigen.
The use of the negative controls (SBF) and blank 
samples showed that the values obtained were 
consistent and very low in all the plates, suggesting 
the absence of non-specific signals in the plate wells.
In this paper a new ELISA test reliable, reproducible, 
and specific for B. bovis and B. bigemina is described 
based on B.  bigemina AMA-1 protein, which 
is an apically located protein shared by many 
Apicomplexa. These proteins show common 
features and are enclosed in the AMA-1 protein 
family whose members are characterised by 
the presence of a Signal Peptide for membrane 
targeting, a Trans-membrane helix (TM), and 
disulphure bonds dividing the protein in functional 
domains. Apical Membrane Antigen-1 members 
have a key role in the host red cell invasion process 
and are extensively studied for their possible 
inclusion in a subunit vaccine. Sequence analyses 
showed the presence of regions highly conserved 
Table I. Results of B. bigemina Apical Membrane Antigen-1 ELISA assay performed on serum samples divided into 6 groups according to their positivity/
negativity to B. bigemina, B. bovis and T. annulata pathogens. The field serum samples included in the study were taken from a panel of sera and 
DNA samples collected by the Istituto Zooprofilattico Sperimentale della Sicilia from 2011 to 2012 for diagnostic purposes. The samples had been 
previously tested by serological and molecular techniques.
Group 
number B. bigemina B. bovis T. annulata
N° of 
samples
Samples tested by 
serological analyses
Samples tested by 
molecular analyses
Mean O.D. 
value
Standard 
Deviation
1 POS POS POS 26 26 1 1.15 0.11
2 NEG POS NEG 16 9 7 0.99 0.18
3 POS POS NEG 26 10 16 1.15 0.14
4 POS NEG NEG 28 21 7 0.9 0.13
5 NEG NEG POS 22 10 12 0.4 0.13
6 NEG NEG NEG 18 12 6 0.42 0.11
Total 136 87 49
Table II. Results of B. bigemina Apical Membrane Antigen-1 ELISA 
assay performed on serum samples divided into 3 groups obtained 
by the association of the samples of Group 1 and Group 3 (Group A), 
Group 2 and Group 4 (Group B), Group 5 and Group 6 (Group C), after 
ANOVA analysis. The field serum samples included in the study 
were taken from a panel of sera and DNA samples collected by the 
Istituto Zooprofilattico Sperimentale della Sicilia from 2011 to 2012 
for diagnostic purposes. The samples had been previously tested by 
serological and molecular techniques.
Group B. bigemina
B. 
bovis
T. 
annulata
N° of 
samples
Mean 
O.D. 
value
Standard 
Deviation
A
POS POS POS
52 1.15 0.12
POS POS NEG
B
NEG POS NEG
44 0.94 0.15
POS NEG NEG
C
NEG NEG POS
40 0.41 0.12
NEG NEG NEG
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Figure 2. Amino acidic alignment of the B. bigemina and B. bovis Apical Membrane Antigen 1 (AMA-1).
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